EMA provides guidance on development of medicines to prevent stroke in patients with atrial fibrillation – comments invited

View source ↗

Summary

EMA publishes guidance to help develop medicines aimed at preventing stroke in patients with atrial fibrillation and invites comments from stakeholders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke